Abstract

BackgroundHypoglycaemia is a common and potentially life threatening consequence of insulin and sulphonylurea treated Diabetes. Some severe hypoglycaemic events result in emergency ambulance attendance. Many of these patients are treated at home and do not require immediate transportation to an Emergency Department. However only 27-37 % of patients then follow up their care with a diabetes specialist. Consequently repeat severe hypoglycaemic events occur.MethodsThe intervention was implemented for 8 months, using a prospective cohort design with a historic control, in one Scottish Health Board in 2012. Data was collected using postal survey questionnaires to patients and ambulance clinicians, telephone survey follow-up questions to patients. Scottish Ambulance Service electronic records were linked with the SCI-Diabetes database of patient records to enable objective measurement of follow-up behaviour.ResultsAmbulance clinicians’ (n = 92) awareness of the intervention was high and both the prompt card and telephone call components of the intervention were delivered to most eligible patients. The intervention was perceived as highly acceptable to patients (n = 37), and very useful by both patients and ambulance clinicians. However, comparison of patient follow-up behaviours using linked-data (n = 205), suggest that the intervention was unsuccessful in improving rates of patients’ following up their care.ConclusionsThis study shows that the intervention is implementable, highly acceptable to patients, and considered very useful by both patients and ambulance clinicians. However, preliminary evidence of effectiveness is not encouraging. The study’s novel use of linking existing clinical data for outcome measurement exposed challenges in the feasibility of using this data for intervention development and evaluation. Future research should examine challenges to the successful testing and effectiveness of the intervention. Revisions are likely to be required, both to study design and the optimisation of the intervention’s content and components.Electronic supplementary materialThe online version of this article (doi:10.1186/s12873-016-0078-1) contains supplementary material, which is available to authorized users.

Highlights

  • Hypoglycaemia is a common and potentially life threatening consequence of insulin and sulphonylurea treated Diabetes

  • Severe hypoglycaemia, defined as a person requiring external assistance to treat, is a serious condition which can lead to coma, seizure, and death

  • In type 2 diabetes mellitus the prevalence is less, but incidence rises with length of duration of insulin or sulphonylurea therapy [1]

Read more

Summary

Introduction

Hypoglycaemia is a common and potentially life threatening consequence of insulin and sulphonylurea treated Diabetes. Some severe hypoglycaemic events result in emergency ambulance attendance. Many of these patients are treated at home and do not require immediate transportation to an Emergency Department. Hypoglycaemia is a common adverse effect of insulin and sulphonylurea treated Diabetes Mellitus. Severe hypoglycaemia, defined as a person requiring external assistance to treat, is a serious condition which can lead to coma, seizure, and death. The annual prevalence of severe hypoglycaemia among patients with type 1 diabetes mellitus is approximately 30 %, with the incidence increasing due to disease duration, amongst other factors. In type 2 diabetes mellitus the prevalence is less, but incidence rises with length of duration of insulin or sulphonylurea therapy [1]. Recurrent episodes of severe hypoglycaemia can cause permanent cognitive impairment leading to cognitive decline and an acceleration of the onset of dementia [1]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.